In last trading session, Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) saw 0.87 million shares changing hands with its beta currently measuring -0.92. Company’s recent per share price level of $0.17 trading at $0.01 or 5.00% at ring of the bell on the day assigns it a market valuation of $6.80M. That closing price of COEP’s stock is at a discount of -711.76% from its 52-week high price of $1.38 and is indicating a premium of 5.88% from its 52-week low price of $0.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.14 million shares which gives us an average trading volume of 173.59K if we extend that period to 3-months.
Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) trade information
Upright in the green during last session for gaining 5.00%, in the last five days COEP remained trading in the red while hitting it’s week-highest on Monday, 09/23/24 when the stock touched $0.17 price level, adding 8.06% to its value on the day. Coeptis Therapeutics Holdings Inc’s shares saw a change of -78.29% in year-to-date performance and have moved -5.44% in past 5-day. Coeptis Therapeutics Holdings Inc (NASDAQ:COEP) showed a performance of -12.54% in past 30-days. Number of shares sold short was 37007.0 shares which calculate 0.24 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Coeptis Therapeutics Holdings Inc (COEP) estimates and forecasts
Statistics highlight that Coeptis Therapeutics Holdings Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -42.77% of value to its shares in past 6 months, showing an annual growth rate of 70.79% while that of industry is 17.70. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -311.69% during past 5 years.
Coeptis Therapeutics Holdings Inc (NASDAQ:COEP)’s Major holders
Insiders are in possession of 23.91% of company’s total shares while institution are holding 4.22 percent of that, with stock having share float percentage of 5.55%. Investors also watch the number of corporate investors in a company very closely, which is 4.22% institutions for Coeptis Therapeutics Holdings Inc that are currently holding shares of the company.
